Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

September 6, 2022

Study Completion Date

September 6, 2022

Conditions
Presbyopia
Interventions
DRUG

Pilocarpine Ophthalmic Topical Cream, Dose 1

Pilocarpine Ophthalmic Topical Cream, Dose 1

DRUG

Pilocarpine Ophthalmic Topical Cream, Dose 2

Pilocarpine Ophthalmic Topical Cream, Dose 2

DRUG

Pilocarpine Ophthalmic Topical Cream, Dose 3

Pilocarpine Ophthalmic Topical Cream, Dose 3

DRUG

Placebo Ophthalmic Topical Cream

Placebo Ophthalmic Topical Cream

Trial Locations (10)

14618

Glaukos Investigator, Rochester

38119

Glaukos Investigator, Memphis

40206

Glaukos Investigator, Louisville

77025

Glaukos Investigator, Houston

78229

Glaukos Investigator, San Antonio

85224

Glaukos Investigator, Chandler

85351

Glaukos Investigator, Sun City

91204

Glaukos Investigator, Glendale

92663

Glaukos Investigator, Newport Beach

94954

Glaukos Investigator, Petaluma

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY

NCT05124275 - Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia | Biotech Hunter | Biotech Hunter